Literature DB >> 16503879

Role of P1 residues Arg336 and Arg562 in the activated-Protein-C-catalysed inactivation of Factor VIIIa.

Fatbardha Varfaj1, Julie Neuberg, P Vincent Jenkins, Hironao Wakabayashi, Philip J Fay.   

Abstract

APC (activated Protein C) inactivates human Factor VIIIa following cleavage at residues Arg336 and Arg562 within the A1 and A2 subunits respectively. The role of the P1 arginine in APC-catalysed inactivation of Factor VIIIa was examined by employing recombinant Factor VIIIa molecules where residues 336 and 562 were replaced with alanine and/or glutamine. Stably expressed Factor VIII proteins were activated by thrombin and resultant Factor VIIIa was reacted at high concentration with APC to minimize cofactor inactivation due to A2 subunit dissociation. APC cleaved wild-type Factor VIIIa at the A1 site with a rate approximately 25-fold greater than that for the A2 site. A1 mutants R336A and R336Q were inactivated approximately 9-fold slower than wild-type Factor VIIIa, whereas the A2 mutant R562A was inactivated approximately 2-fold slower. No cleavage at the mutated sites was observed. Taken together, these results suggested that cleavage at the A1 site was the dominant mechanism for Factor VIIIa inactivation catalysed by the proteinase. On the basis of cleavage at Arg336, a K(m) value for wild-type Factor VIIIa of 102 nM was determined, and this value was significantly greater than K(i) values (approximately 9-18 nM) obtained for an R336Q/R562Q Factor VIIIa. Furthermore, evaluation of a series of cluster mutants in the C-terminal region of the A1 subunit revealed a role for acidic residues in segment 341-345 in the APC-catalysed proteolysis of Arg336. Thus, while P1 residues contribute to catalytic efficiency, residues removed from these sites make a primary contribution to the overall binding of APC to Factor VIIIa.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16503879      PMCID: PMC1462720          DOI: 10.1042/BJ20060117

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  32 in total

1.  Cofactor activities of factor VIIIa and A2 subunit following cleavage of A1 subunit at Arg336.

Authors:  Mary E Koszelak Rosenblum; Kyla Schmidt; Jan Freas; Maria Mastri; Philip J Fay
Journal:  J Biol Chem       Date:  2002-01-17       Impact factor: 5.157

2.  Altered interactions between the A1 and A2 subunits of factor VIIIa following cleavage of A1 subunit by factor Xa.

Authors:  Keiji Nogami; Hironao Wakabayashi; Kyla Schmidt; Philip J Fay
Journal:  J Biol Chem       Date:  2002-11-07       Impact factor: 5.157

3.  Extended interactions with prothrombinase enforce affinity and specificity for its macromolecular substrate.

Authors:  Steven J Orcutt; Concetta Pietropaolo; Sriram Krishnaswamy
Journal:  J Biol Chem       Date:  2002-10-04       Impact factor: 5.157

4.  Molecular characterization of an extended binding site for coagulation factor Va in the positive exosite of activated protein C.

Authors:  Andrew J Gale; Alexander Tsavaler; John H Griffin
Journal:  J Biol Chem       Date:  2002-06-12       Impact factor: 5.157

5.  Identification of a factor Xa-interactive site within residues 337-372 of the factor VIII heavy chain.

Authors:  Keiji Nogami; Kirsty A Lapan; Qian Zhou; Hironao Wakabayashi; Philip J Fay
Journal:  J Biol Chem       Date:  2004-02-04       Impact factor: 5.157

Review 6.  Activation of factor VIII and mechanisms of cofactor action.

Authors:  Philip J Fay
Journal:  Blood Rev       Date:  2004-03       Impact factor: 8.250

7.  Residues 110-126 in the A1 domain of factor VIII contain a Ca2+ binding site required for cofactor activity.

Authors:  Hironao Wakabayashi; Jan Freas; Qian Zhou; Philip J Fay
Journal:  J Biol Chem       Date:  2004-01-13       Impact factor: 5.157

8.  Thrombin-catalyzed activation of factor VIII with His substituted for Arg372 at the P1 site.

Authors:  Keiji Nogami; Qian Zhou; Hironao Wakabayashi; Philip J Fay
Journal:  Blood       Date:  2005-02-10       Impact factor: 22.113

9.  Exosite-dependent regulation of factor VIIIa by activated protein C.

Authors:  Chandrashekhara Manithody; Philip J Fay; Alireza R Rezaie
Journal:  Blood       Date:  2003-02-20       Impact factor: 22.113

10.  Mechanisms of factor Xa-catalyzed cleavage of the factor VIIIa A1 subunit resulting in cofactor inactivation.

Authors:  Keiji Nogami; Hironao Wakabayashi; Philip J Fay
Journal:  J Biol Chem       Date:  2003-02-26       Impact factor: 5.157

View more
  9 in total

1.  Noncovalent stabilization of the factor VIII A2 domain enhances efficacy in hemophilia A mouse vascular injury models.

Authors:  Lilley Leong; Derek Sim; Chandra Patel; Katherine Tran; Perry Liu; Elena Ho; Thomas Thompson; Peter J Kretschmer; Hironao Wakabayashi; Philip J Fay; John E Murphy
Journal:  Blood       Date:  2014-10-20       Impact factor: 22.113

2.  Sequences flanking Arg336 in factor VIIIa modulate factor Xa-catalyzed cleavage rates at this site and cofactor function.

Authors:  Jennifer P DeAngelis; Hironao Wakabayashi; Philip J Fay
Journal:  J Biol Chem       Date:  2012-03-12       Impact factor: 5.157

3.  The role of P4-P3' residues flanking Arg336 in facilitating activated protein C-catalyzed cleavage and inactivation of factor VIIIa.

Authors:  Jennifer P DeAngelis; Fatbardha Varfaj; Hironao Wakabayashi; Philip J Fay
Journal:  Thromb Res       Date:  2011-04-05       Impact factor: 3.944

4.  Contribution of factor VIII light-chain residues 2007-2016 to an activated protein C-interactive site.

Authors:  Masahiro Takeyama; Hironao Wakabayashi; Philip J Fay
Journal:  Thromb Haemost       Date:  2012-12-06       Impact factor: 5.249

5.  Variable contributions of basic residues forming an APC exosite in the binding and inactivation of factor VIIIa.

Authors:  Masahiro Takeyama; Jennifer M Wintermute; Chandrashekhara Manithody; Alireza R Rezaie; Philip J Fay
Journal:  Biochemistry       Date:  2013-03-22       Impact factor: 3.162

6.  Detailed mechanisms of the inactivation of factor VIIIa by activated protein C in the presence of its cofactors, protein S and factor V.

Authors:  Andrew J Gale; Thomas J Cramer; Diana Rozenshteyn; Jason R Cruz
Journal:  J Biol Chem       Date:  2008-04-18       Impact factor: 5.157

7.  Combining mutations that modulate inter-subunit interactions and proteolytic inactivation enhance the stability of factor VIIIa.

Authors:  H Wakabayashi; J M Wintermute; P J Fay
Journal:  Thromb Haemost       Date:  2014-03-06       Impact factor: 5.249

8.  Replacing the factor VIII C1 domain with a second C2 domain reduces factor VIII stability and affinity for factor IXa.

Authors:  Hironao Wakabayashi; Philip J Fay
Journal:  J Biol Chem       Date:  2013-09-12       Impact factor: 5.157

Review 9.  Protein-Engineered Coagulation Factors for Hemophilia Gene Therapy.

Authors:  Benjamin J Samelson-Jones; Valder R Arruda
Journal:  Mol Ther Methods Clin Dev       Date:  2018-12-31       Impact factor: 6.698

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.